Align Technology, Inc. ALGN
146.78
1.15
0.79%
as of 25 Sep
- Market cap
- $10.4B
- P/E
- 25.5×
Follow ALGN
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Align Technology, Inc. (ALGN) P/S ratio
As of 25 September 2026, Align Technology, Inc. (ALGN) trades at a P/S ratio of 2.5×. Over the past ten years it has ranged from 2.3× (September 2025) to 19.8× (February 2021); the current reading is higher than 2% of that period. That is below the Medical Instruments & Supplies industry median of 2.8× and below the Healthcare sector median of 3.8×.
P/S ratio, daily
Annual
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 2.8× | (28.09%) |
| FY2024 | 3.9× | (26.63%) |
| FY2023 | 5.3× | 19.73% |
| FY2022 | 4.4× | (66.13%) |
| FY2021 | 13.1× | (22.94%) |
| FY2020 | 17.0× | 84.90% |
| FY2019 | 9.2× | 7.99% |
| FY2018 | 8.5× | (30.16%) |
| FY2017 | 12.2× | 70.28% |
| FY2016 | 7.2× | 15.08% |
Quarterly
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 2.9× | (2.56%) |
| Mar 2026 | 3.0× | 6.49% |
| Dec 2025 | 2.8× | 23.37% |
| Sep 2025 | 2.3× | (34.33%) |
| 42 more quarters | Free account |
Against its own ten years
Low 2.3×
High 19.8×
Ten-year median
6.9×
Current reading's percentile
2
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| BAX Baxter International Inc. compare | 1.1× |
| BLCO Bausch + Lomb Corporation compare | 1.1× |
| AVTR Avantor, Inc. compare | 1.6× |
| SOLV Solventum Corporation compare | 1.9× |
| ATR AptarGroup, Inc. compare | 2.0× |
| COO The Cooper Companies, Inc. compare | 2.5× |
| ALGN Align Technology, Inc. | 2.5× |
| STVN Stevanato Group S.p.A. compare | 4.0× |
| RGEN Repligen Corporation compare | 13.6× |
| Medical Instruments & Supplies industry median | 2.8× |
| Healthcare sector median | 3.8× |
| Market median | 2.0× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on ALGN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement